{"doi":"10.1080/10550490500419094","title":"Transferring Methadone‐Stabilized Pregnant Patients to Buprenorphine Using an Immediate Release Morphine Transition: An Open‐Label Exploratory Study","abstract":"<jats:p>A transition from methadone to buprenorphine without intervening withdrawal symptoms is critical for advancing the treatment of opioid‐dependent patients. Four pregnant inpatients were transferred from methadone (65–85 mg) to five days of immediate release morphine (IRM) and then to buprenorphine (12–28 mg). Withdrawal scores decreased during the five days of IRM and subsequently increased over the first three days on buprenorphine. The transitional use of IRM appears safe for both mother and fetus. Withdrawal symptoms appeared during buprenorphine induction; however, these data suggest that the intensity of withdrawal symptoms may be lessened by the dose and frequency of buprenorphine administration.</jats:p>","journal":"The American Journal on Addictions","year":2006,"id":37522,"datarank":1.7404828557147505,"base_score":3.1780538303479458,"endowment":3.1780538303479458,"self_citation_contribution":0.47670807455219194,"citation_network_contribution":1.2637747811625586,"self_endowment_contribution":0.47670807455219194,"citer_contribution":1.2637747811625586,"corpus_percentile":null,"corpus_rank":null,"citation_count":23,"citer_count":18,"citers_with_citation_signal":15,"citers_with_endowment":15,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":187856,"name":"Patricia Suess","orcid":null,"position":1,"is_corresponding":false},{"id":180276,"name":"Donald R. Jasinski","orcid":null,"position":2,"is_corresponding":false},{"id":187857,"name":"Rolley E. Johnson","orcid":null,"position":3,"is_corresponding":false},{"id":187855,"name":"Hendrée E. Jones","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":3.1780538303479458,"endowment":3.1780538303479458,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"16449094","pmcid":null,"openalex_id":"https://openalex.org/W2087129163","authors":[],"funders":[{"funder_name":"NCRR NIH HHS","grant_id":"M01RR-02719","title":null},{"funder_name":"PHS HHS","grant_id":"R01 12220","title":null}],"total_grants":2,"fwci":4.429,"citation_percentile":0.9358169,"influential_citations":0,"citation_trend":[{"year":2012,"count":6},{"year":2013,"count":1},{"year":2014,"count":1},{"year":2016,"count":1},{"year":2019,"count":1},{"year":2022,"count":1}],"oa_status":"closed","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","oa_locations":[{"url":"http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1080%2F10550490500419094","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1080/10550490500419094","host_type":"publisher"},{"url":"https://doi.org/10.1080/10550490500419094","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/16449094","host_type":"repository"}],"fields_of_study":["Prenatal Substance Exposure Effects","Opioid Use Disorder Treatment","Maternal Mental Health During Pregnancy and Postpartum","Medicine","Adult","Buprenorphine","Delayed-Action Preparations","Dose-Response Relationship, Drug","Drug Administration Schedule","Drug Therapy, Combination","Female","Humans","Infant, Newborn","Methadone","Morphine","Narcotic Antagonists","Narcotics","Neonatal Abstinence Syndrome","Neurologic Examination","Opioid-Related Disorders","Pregnancy","Pregnancy Complications","Pregnancy Outcome","Substance Withdrawal Syndrome","Treatment Outcome"],"mesh_terms":["Adult","Buprenorphine","Delayed-Action Preparations","Dose-Response Relationship, Drug","Drug Administration Schedule","Drug Therapy, Combination","Female","Humans","Infant, Newborn","Methadone","Morphine","Narcotic Antagonists","Opioid-Related Disorders","Narcotics","Neonatal Abstinence Syndrome","Neurologic Examination","Pregnancy","Pregnancy Complications","Pregnancy Outcome","Substance Withdrawal Syndrome","Treatment Outcome"],"keywords":["Buprenorphine","Methadone","Medicine","Anesthesia","Morphine","Opioid use disorder","Opioid","Pregnancy","Internal medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-10T19:48:35.820312Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}